Search Results - "Roubicek, Ian"

Safety and effectiveness of RBD-specific polyclonal equine F(ab´)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: A retrospective cohort study by Farizano Salazar, Diego H., Achinelli, Fernando, Colonna, Mariana, Pérez, Lucía, Giménez, Analía A., Ojeda, Maria Alejandra, Miranda Puente, Susana N., Sánchez Negrette, Lía, Cañete, Florencia, Martelotte Ibarra, Ornela I., Sanguineti, Santiago, Spatz, Linus, Goldbaum, Fernando A., Massa, Carolina, Rivas, Marta, Pichel, Mariana, Hiriart, Yanina, Zylberman, Vanesa, Gallego, Sandra, Konigheim, Brenda, Fernández, Francisco, Deprati, Matías, Roubicek, Ian, Giunta, Diego H., Nannini, Esteban, Lopardo, Gustavo, Belloso, Waldo H.

“…Background Passive immunotherapy has been evaluated as a therapeutic alternative for patients with COVID-19 disease. Equine polyclonal immunotherapy for…”
Get full text

Open-label, controlled, phase 2 clinical trial assessing the safety, efficacy, and pharmacokinetics of INM004 in pediatric patients with Shiga toxin-producing Escherichia coli–associated hemolytic uremic syndrome by Fayad, Alicia, Principi, Iliana, Balestracci, Alejandro, Alconcher, Laura, Coccia, Paula, Adragna, Marta, Amoreo, Oscar, Bettendorff, María Carolina, Blumetti, María Valeria, Bonany, Pablo, Tonfi, María Laura Flores, Flynn, Luis, Ghezzi, Lidia, Montero, Jorge, Ramírez, Flavia, Seminara, Claudia, Suarez, Ángela, Spizzirri, Ana Paula, Rivas, Marta, Pichel, Mariana, Zylberman, Vanesa, Spatz, Linus, Massa, Carolina, Valerio, Marina, Sanguineti, Santiago, Colonna, Mariana, Roubicek, Ian, Goldbaum, Fernando

“…Abstract Background Shiga toxin-producing Escherichia coli -associated hemolytic uremic syndrome (STEC-HUS) is a severe condition mainly affecting children. It…”
Get full text

Safety and effectiveness of RBD-specific polyclonal equine F.sub.2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: A retrospective cohort study by Farizano Salazar, Diego H, Achinelli, Fernando, Colonna, Mariana, Pérez, Lucía, Giménez, Analía A, Ojeda, Maria Alejandra, Miranda Puente, Susana N, Sánchez Negrette, Lía, Cañete, Florencia, Martelotte Ibarra, Ornela I, Sanguineti, Santiago, Spatz, Linus, Goldbaum, Fernando A, Massa, Carolina, Rivas, Marta, Pichel, Mariana, Hiriart, Yanina, Zylberman, Vanesa, Gallego, Sandra, Konigheim, Brenda, Fernández, Francisco, Deprati, Matías, Roubicek, Ian, Giunta, Diego H, Nannini, Esteban, Lopardo, Gustavo, Belloso, Waldo H

“…Background Passive immunotherapy has been evaluated as a therapeutic alternative for patients with COVID-19 disease. Equine polyclonal immunotherapy for…”
Get full text

Safety and effectiveness of RBD-specific polyclonal equine F by Farizano Salazar, Diego H, Achinelli, Fernando, Colonna, Mariana, Pérez, Lucía, Giménez, Analía A, Ojeda, Maria Alejandra, Miranda Puente, Susana N, Sánchez Negrette, Lía, Cañete, Florencia, Martelotte Ibarra, Ornela I, Sanguineti, Santiago, Spatz, Linus, Goldbaum, Fernando A, Massa, Carolina, Rivas, Marta, Pichel, Mariana, Hiriart, Yanina, Zylberman, Vanesa, Gallego, Sandra, Konigheim, Brenda, Fernández, Francisco, Deprati, Matías, Roubicek, Ian, Giunta, Diego H, Nannini, Esteban, Lopardo, Gustavo, Belloso, Waldo H

“…Background Passive immunotherapy has been evaluated as a therapeutic alternative for patients with COVID-19 disease. Equine polyclonal immunotherapy for…”
Get full text

Safety and effectiveness of RBD-specific polyclonal equine F(ab´)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: A retrospective cohort study by Diego H Farizano Salazar, Fernando Achinelli, Mariana Colonna, Lucía Pérez, Analía A Giménez, Maria Alejandra Ojeda, Susana N Miranda Puente, Lía Sánchez Negrette, Florencia Cañete, Ornela I Martelotte Ibarra, Santiago Sanguineti, Linus Spatz, Fernando A Goldbaum, Carolina Massa, Marta Rivas, Mariana Pichel, Yanina Hiriart, Vanesa Zylberman, Sandra Gallego, Brenda Konigheim, Francisco Fernández, Matías Deprati, Ian Roubicek, Diego H Giunta, Esteban Nannini, Gustavo Lopardo, Waldo H Belloso, EPIC Study Group

“…BackgroundPassive immunotherapy has been evaluated as a therapeutic alternative for patients with COVID-19 disease. Equine polyclonal immunotherapy for…”
Get full text